The role of intraoperative frozen section analysis in the choice of surgical strategy for ovarian tumors


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Malignant ovarian tumors are latent, lack specific clinical and diagnostic markers, and rarely detected at early stages resulting in suboptimal treatment outcomes. Gynecologists and oncologists often have different views of the clinical situation when the organ-sparing approach of gynecologists may run counter to the radical strategy of oncologists. Intraoperative frozen section analysis of ovarian tumors is necessary to determine tumor grade and guide surgical decision-making. Aim. To determine the sensitivity, specificity, and prognostic significance of intraoperative frozen section analysis (IFSA) in the differential diagnosis of ovarian tumors, its role in the choice of surgical strategy, and the feasibility of determining the histopathologic subtype of cancer. Materials and methods. This was a descriptive longitudinal study conducted at the Department of Innovative Oncology and Gynecology, V.I. Kulakov NMRC for OG&P. During the 2-year data collection period, 77 intraoperative frozen section analyses were performed. Results. Among 77 patients with ovarian tumors, frozen section results were reported as benign, malignant, and borderline in 20 (26%), 39 (50.6%), and 18 (23.4%) tumors. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of IFSA for detecting benign tumors were 100%, 93.4%, 77.8%, and 100%, respectively. For the detection of malignant tumors, the sensitivity specificity, PPV, and NPV were 95%, 97.1%, 97.4%, and 94.4%. However, IFSA had a lower sensitivity (76.2%) and PPV (88.9%) for the diagnosis of borderline tumors. In these ovarian neoplasms, specificity and NPV were 96.3% and 91.2%. Conclusion. IFSA is useful in the differential diagnosis of ovarian tumors and helps guide surgical decisionmaking.

Full Text

Restricted Access

About the authors

Julia V. Nosova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: yu_nosova@oparina4.ru
Ph.D. Student

Alina E. Solopova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a_solopova@oparina4.ru
MD, PhD, Associate Professor, Leading Researcher, Department of Radiology

Aleksandra V. Asaturova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: A_asaturova@oparina4.ru
Head of the 1st Department of Anatomic Pathology

Anna V. Tregubova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: A_tregubova@oparina4.ru
Junior Researcher at the 1st Department of Anatomic Pathology

Vlada V. Kometova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_kometova@oparina4.ru
Head of Oncopathology Department

Grigorii N. Khabas

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: g_khabas@oparina4.ru
Ph.D., Head of the Department of Innovative Oncology and Gynecology

References

  1. Management of Suspected Ovarian Masses in Premenopausal Women (Green-top Guideline N 62) [Electronic resource]: RCOG/BSGE Joint Guideline / British Society of Gynecological Endoscopy (BSGE). London: RCOG, 2011. URL: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/ gtg62.
  2. Макаров О.В., Борисенко С.А. Профилактика, диагностика, лечение рака яичников. Российский медицинский журнал. 1996; 3: 36-40. [Makarov O.V., Borisenko S.A. Prophylaxis, diagnosis, treatment of ovarian cancer. Medical Journal of the Russian Federation. 1996; 3: 36-40. (in Russian)].
  3. Гаспаров А. С., Жорданиа К.И., Паяниди Ю.Г., Дубинская Е.Д. Онкогинекологические аспекты кистозных образований яичников. Вестник Российской академии медицинских наук. 2013; 68(8): 9-13.
  4. Permuth-Wey J., Besharat A., Sellers T. Epidemiology of ovarian cancer: An update. In: Advances in diagnosis and management of ovarian cancer. Farghaly S.A., editor. New York: Springer Science and Business Media; 2014. PMID: None.
  5. Wentzensen N, Poole E.M., Trabert B. et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol. 2016;34(24):2888-98. PMID: 27325851. http://dx.doi.org/10.1200/ JC0.2016.66.8178.
  6. Song H, Ramus S.J., Tyrer J. et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet. 2009; 41(9): 9961000. PMID: 19648919. http://dx.doi.org/10.1038/ng.424.
  7. Pharoah P.D., Tsai Y.Y., Ramus S.J. et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013;45(4):362-70, 70e1-2. PMID: 23535730. http://dx.doi.org/10.1038/ ng.2564.
  8. Permuth-Wey J., Lawrenson K., Shen H.C. et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun. 2013; 4: 1627. PMID: 23535648. http://dx.doi.org/10.1038/ ncomms2613.
  9. Kuchenbaecker K.B., Ramus S.J., Tyrer J. et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015;47(2):164-71. PMID: 25581431. http://dx.doi.org/10.1038/ng.3185.
  10. Bolton K.L., Tyrer J., Song H. et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010;42(10):880-4. PMID: 20852633. http://dx.doi.org/10.1038/ng.666.
  11. Bojesen S.E., Pooley K.A., Johnatty S.E. et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013;45(4):371-84, 84e1-2. PMID: 23535731. http://dx.doi.org/10.1038/ng.2566.
  12. National Institute for Health and Care Excellence (NICE). Clinical guideline [CG164]: Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. 2013. PMID: None.
  13. Daly M.B., Pilarski R., Axilbund J.E. et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016;14(2):153-62. PMID: 26850485. http://dx.doi.org/10.6004/ jnccn.2016.0018.
  14. Moyer V.A., Force USPST. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(4):271-81. PMID: 24366376. http://dx.doi.org/10.7326/M13-2747.
  15. Domchek S.M., Friebel T.M., Singer C.F. et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967-75. PMID: 20810374. http://dx.doi.org/10.1001/ jama.2010.1237.
  16. Jayson G.C., Kohn E.C., Kitchener H.C., Ledermann J.A. Ovarian cancer. Lancet. 2014;384:1376-1388.
  17. Chien J., Poole E. Ovarian cancer prevention, screening and early detection: report from the 11th Biennial Ovarian Cancer Research Symposium. Int J Gynecol Cancer. 2018;27:20-22.
  18. Institute of Medicine, Committee on the State of the Science in Ovarian Cancer Research, Board on Health Care Services, et al. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington (DC): National Academies Press (US); 2016. PMID: 27253000.
  19. Pavlakis K., Messini I., Vrekoussis T., Yiannou P., Panoskaltsis T., Voulgaris Z. Intraoperative assessment of epithelial and non-epithelial ovarian tumors: a 7-year review. Eur J Gynaecol Oncol. 2009;30(6):657-60.
  20. Sukumaran R., Somanathan T., Mathews A., Kattor J., Sambasivan S., Nair R.P. Role of frozen section in intraoperative assessment of ovarian masses: a tertiary oncology center experience. Indian J Surg Oncol.2014;5(2):99-103. https://doi. org/10.1007/s13193-014-0311-x.
  21. Kurman R., Carcangiu M., Herrington C., Young R.H. WHO Classification of tumours of female reproductive organs.Lyon: IARC Press; 2014.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies